Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Miltefosine (miltefosine systemic) is a member of the following drug classes: anthelmintics, miscellaneous antineoplastics and is used to treat Leishmaniasis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent

Chemical Name

Choline hydroxide, hexadecyl hydrogen phosphate, inner salt

Foreign Names

  • Miltefosinum (Latin)
  • Miltefosin (German)
  • Miltefosine (French)
  • Miltefosina (Spanish)

Generic Names

  • Miltefosine (OS: BAN)
  • D-18506 (IS)
  • HDPC (IS)
  • Hexadecylphosphocholine (IS)

Brand Names

  • Impavido
    Medicamenta Ecuatoriana, Ecuador; Paladin, United States; Paladin Labs, Germany
  • Milteforan (veterinary use)
    Virbac, Switzerland; Virbac, Italy
  • Miltex
    Baxter, Chile; Baxter, Spain; Baxter, Lithuania


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.